Alibaba Health Information Technology

What Alibaba Health Information Technology does

Alibaba Health Information Technology (HKEX: 00241) is a Hong Kong-listed digital health and pharmaceutical e-commerce platform headquartered in Beijing and incorporated in Bermuda, with Alibaba Group as its 44% controlling shareholder. The company operates three core segments: a pharmaceutical self-operated B2C pharmacy business, a pharmaceutical e-commerce marketplace/platform business, and a healthcare and digital services segment delivering telemedicine, consultations, and AI-enabled clinical tools to consumers and professionals. Its platform hosts more than 220,000 physicians, pharmacists, and nutritionists and processes over 110,000 daily consultations, supported by what the company describes as Asia's largest digital single-drug warehouse and integrated Cainiao Smart Logistics fulfillment.

The company is organized around a "Three Cloud" strategy spanning Cloud Pharmacy (drug supply and retail), Cloud Infrastructure (technology and data systems), and Cloud Hospital (online care delivery), executed through the Alibaba Group ecosystem including Taobao, Tmall, Alipay, and Ele.me. Underlying technology assets include a Medical AI Knowledge Graph, the Fire Eye (火眼系统) AI supplier risk-monitoring platform, the 码上放心 drug tracing system, and a proprietary Medical Large Model, with patent authorizations growing 57% year-over-year.

Alibaba Health generates revenue primarily through direct pharmaceutical sales on its B2C platform, marketplace commissions and marketing services from third-party merchants, and fees from healthcare and digital services such as telemedicine consultations and enterprise solutions. The company serves a highly fragmented end-customer base of individual Chinese consumers purchasing OTC and prescription drugs online, alongside healthcare professionals and ecosystem partners; corporate-level customer concentration is therefore low at the user level but moderate at the related-party/ecosystem level given deep Alibaba Group integration. FY2025 disclosed revenue reached CNY 33 billion (~$4.6B USD), up 17% year-over-year, with EPS up 52% to CNY 0.12. Leadership underwent refresh in late 2025–early 2026 with Shen Difan as Chairman and Sheng Mengyue as Executive Director and CFO.

Name

Alibaba Health Information Technology

Legal name

Alibaba Health Information Technology Limited

Website

https://alihealth.cn

Company type

Public

Founded year

1972

Operating status

Operating

Headcount range

251–500 employees

Short description

Alibaba Health Information Technology (HKEX: 00241) is a Beijing-headquartered digital health platform that operates pharmaceutical e-commerce, telemedicine, and AI-enabled healthcare services for Chinese consumers and professionals, distributed through the Alibaba Group ecosystem including Taobao and Tmall.

Ownership category

akta.pro rank

Product category

Online Pharmacy and Digital Healthcare

NAICS

Pharmacies and Drug Retailers (456110)

SIC

Services-Misc Health & Allied Services, Nec (8090), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA)

akta.pro secondary industries

Telehealth-to-Pharmacy Marketplace & Prescription Routing Platforms (HLALAIAC), Virtual Pharmacy & Medication Management Integration Platforms (HLALABAL), Pharmacy & Health Essentials Delivery (CRAFAFAI)

Keywords

• Online pharmaceutical retail
• Digital healthcare services
• Telemedicine consultations
• Drug traceability systems
• Healthcare e-commerce platform

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Digital Commerce or Content

Cost components

Supply Chain, Technology or R&D, Infrastructure, Personnel, Marketing or Sales, Operations

Revenue model

1. Pharmaceutical Self-operated Business (医药自营业务): Self-operated online pharmacy (阿里健康大药房) selling prescription drugs, OTC, health supplements, medical devices, and contact lenses directly to consumers through Tmall, Taobao, Alipay, and Ele.me platforms. Revenue from product sales with growing ARPU.
2. Pharmaceutical E-commerce Platform Business (医药电商平台业务): Platform services connecting third-party merchants and consumers, generating commission and service fees from the marketplace model.
3. Healthcare and Digital Services (医疗健康及数字化服务业务): Digital health services including online consultations, telemedicine, chronic disease management, preventive health checkups, vaccines, and home monitoring services.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Alibaba Health Information Technology operates a digital healthcare platform built around the 'Three Clouds' strategy (Cloud Pharmacy, Cloud Infrastructure, Cloud Hospital) that combines self-operated online pharmacy sales of prescription drugs, OTC medications, health supplements, medical devices, and contact lenses with a third-party pharmaceutical marketplace and digital health services including online medical consultations, chronic disease management, preventive health checkups, and TCM telehealth, all distributed through the Alibaba ecosystem (Taobao, Tmall, Alipay, Ele.me).

Product overview

Alibaba Health Information Technology is a comprehensive health tech platform operating a platform-plus-modules architecture built around its 'Three Clouds' (三朵云) strategy: Cloud Infrastructure (云基建), Cloud Pharmacy (云药房), and Cloud Hospital (云医院). The core products consist of three main business segments: pharmaceutical self-operated e-commerce (阿里健康大药房), pharmaceutical e-commerce platform business (天猫健康), and healthcare & digital services. Key branded offerings include Alibaba Health Pharmacy (self-operated pharmacy with 1.23 million SKUs), Tmall Health (platform marketplace), Xiao Lu Zhong Yi (TCM telehealth), the 码上放心 drug traceability system, and the Medical Large Model AI system. The platform serves consumers across Tmall, Taobao, Alipay, and Ele.me channels, providing online consultations with 220,000+ physicians, pharmacists, and nutritionists handling 110,000+ daily consultations.

Differentiator

Problem solved

Functional benefit

Brands

• Alibaba Health Pharmacy (阿里健康大药房): Self-operated pharmacy business under Alibaba Health, integrated with nearly 100 Tmall stores including overseas, pharmaceutical, and self-operated brand flagship stores.
• Tmall Health (天猫健康)
• Xiaolu Zhongyi (小鹿中医)
• Three Clouds Strategy (三朵云)
• Ma Shang An Xin (码上放心)

Products and services

• Alibaba Health Pharmacy (阿里健康大药房) Self-operated online pharmacy selling prescription drugs, OTC medications, health supplements, medical devices, and contact lenses directly to consumers, integrating nearly 100 Tmall stores into an online-offline pharmaceutical service platform.
• Tmall Health (天猫健康) Healthcare marketplace on the Tmall platform that connects third-party pharmaceutical and health product merchants with consumers, providing digital pharmacy operations and marketing capabilities.
• Xiao Lu Zhong Yi (小鹿中医) — Little Deer TCM Traditional Chinese medicine telehealth service platform that provides online consultations with TCM practitioners, patient management, and herbal medicine prescriptions to consumers in China.
• Cloud Hospital (云医院) Digital hospital service offering Western and Traditional Chinese Medicine departments, membership-based patient management, preventive health checkups, vaccinations, and home monitoring, delivered via Alibaba Health's digital platform.
• Online Medical Consultation Service 24/7 online medical consultation service providing access to 220,000+ physicians, pharmacists, and nutritionists, with daily consultations exceeding 110,000 and an 85% customer satisfaction rate.
• Drug Tracing System Service (Ma Shang Fang Xin / 码上放心) Drug traceability and authentication service that provides electronic drug inspection reports across the full drug lifecycle, ensuring supply chain authenticity and safety.
• Preventive Health Checkups and Vaccination Services Preventive health checkup and vaccination services offered to consumers as part of Alibaba Health's digital healthcare services portfolio under the Cloud Hospital framework.
• Chronic Disease Management and Home Monitoring Service Chronic disease management, regular health monitoring, and home monitoring services delivered through Alibaba Health's digital healthcare services platform for patients with ongoing care needs.

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Ant GroupcoreOthersAnt Group (Jack Ma-backed fintech) is a competitor in the AI health sector while also operating within Alibaba's broader ecosystem. Both companies compete in the estimated 480 billion yuan annual digital healthcare market.
• Cainiao Smart LogisticscoreStrategic or Co-development PartnerCainiao (Alibaba's logistics subsidiary) provides green logistics and supply chain capabilities supporting Alibaba Health's pharmaceutical e-commerce and distribution operations with sustainable delivery solutions.
• Alibaba Cloud (阿里云)coreTechnology or IntegrationAlibaba Cloud provides green data center infrastructure supporting Alibaba Health's cloud-based healthcare platform, enabling scalable digital health services with sustainable computing capabilities.
• China Anti-Cancer AssociationminorStrategic or Co-development PartnerPartnership for the 'Health Intelligence Medical' (健康智医) action launched in April 2024 to advance early cancer screening and treatment through digital health solutions.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• CVS Health: Large incumbent combining pharmacy retail, PBM, and digital health services. Useful as a benchmark for where a pharmacy-led digital health platform can scale into integrated care and data-driven services at maturity.
• Tencent Health: Broader incumbent within China's internet healthcare space, leveraging WeChat and mini-program distribution. Competes with Alibaba Health on consumer health engagement, online consultations, and digital health infrastructure.
• Amazon Pharmacy: U.S. online pharmacy embedded within Amazon's consumer ecosystem. Comparable business model — e-commerce giant leveraging logistics and digital storefront to disintermediate pharmacy retail — though operating in a different regulatory and geographic market.

Direct peers

• JD Health International: Hong Kong-listed online pharmacy and telehealth platform operated by JD.com. Directly competes with Alibaba Health in Chinese DTC pharmacy, prescription drug e-commerce, and online consultations, with similar reliance on a parent e-commerce ecosystem for traffic.
• Ping An Healthcare and Technology: Affiliated with Ping An Insurance, operates a leading Chinese online medical consultation and chronic care management platform. Directly comparable as a scaled, ecosystem-anchored telehealth + healthcare services provider competing for the same consumer health wallet.
• WeDoctor (We Dao Jia Yi): One of China's largest online hospital and appointment-booking platforms offering online consultations, prescriptions, and chronic disease management. Overlaps Alibaba Health on telehealth consultations and prescription routing to partner pharmacies.
• 111 Inc. Nasdaq-listed Chinese online pharmacy operating a B2B drug distribution platform (1 Pharmacy) and B2C platform (1 Drugstore). Directly competes in online prescription/OTC drug retail with comparable digital supply chain capabilities.
• Ant Group (Alipay Health / AI Health): Within the broader Alibaba ecosystem, Ant Group operates competing digital health offerings through Alipay, explicitly identified as a rival in the AI health sector for the same Chinese digital healthcare market.

Emerging players

• JD.com Healthcare / Meituan Medicine: Meituan's on-demand pharmaceutical delivery and health services layer uses its super-app logistics network for drug delivery. Comparable to Alibaba Health's Ele.me-enabled pharmacy delivery and on-demand healthcare commerce.
• DXY (Dingxiang Yuan): Major Chinese online physician community and digital health information platform extending into telemedicine and consumer health. Comparable as a digital health platform combining content, practitioner engagement, and consumer services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries3 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments10 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alibaba Health Information Technology